Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children.

Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children.

<h4>Background</h4>Urinary schistosomiasis, the result of infection by Schistosoma haematobium (Sh), remains a major global health concern. A schistosome vaccine could represent a breakthrough in schistosomiasis control strategies, which are presently based on treatment with praziquantel...

Full description

Bibliographic Details
Main Authors: Gilles Riveau, Anne-Marie Schacht, Jean-Pierre Dompnier, Dominique Deplanque, Modou Seck, Nawal Waucquier, Simon Senghor, Delphine Delcroix-Genete, Emmanuel Hermann, Noureddine Idris-Khodja, Claire Levy-Marchal, Monique Capron, André Capron
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-12-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0006968

Internet

https://doi.org/10.1371/journal.pntd.0006968

Similar Items